Y10S977/911 - CPC Classification Index

ClassID:

243699 ⎘

Y10S977/911 - CPC Classification

Classification description:

Nanotechnology; Specified use of nanostructure for medical, immunological, body treatment, or diagnosis; Mechanical repair performed/surgical Cancer cell destruction

Recent Application in this class:

20200170960

2020-06-04

PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED NANOPARTICLES FOR THERAPY OF PROSTATE CANCER

20170135961

2017-05-18

Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer

20160367481

2016-12-22

Cancer cell targeting using nanoparticles

20160022824

2016-01-28

Nanoparticle comprising hydrophobic drug conjugated to cationic polymer and hydrophilic drug conjugated to anionic polymer

20150328485

2015-11-19

Nanoparticle-assisted ultrasound for breast cancer therapy

20140363490

2014-12-11

Oligomer-contained nanoparticle complex release system

20140335156

2014-11-13

Nanoparticle-assisted ultrasound for cancer therapy

20140235706

2014-08-21

Cancer cell targeting using nanoparticles

20140212479

2014-07-31

Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers

#10

20140207126

2014-07-24

Bioconjugated nanoparticles

#11

20140039070

2014-02-06

Compositions and methods of delivery of pharmacological agents

#12

20140039069

2014-02-06

Compositions and methods of delivery of pharmacological agents

#13

20130302508

2013-11-14

Water dispersible glyceryl monooleate magnetic nanoparticle formulation

#14

20130244952

2013-09-19

Compositions and methods of delivery of pharmacological agents

#15

20120283205

2012-11-08

COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS

#16

20120259205

2012-10-11

Method and composition for hyperthermally treating cells

#17

20120226139

2012-09-06

Method and composition for hyperthermally treating cells

#18

20120143043

2012-06-07

Method and composition for hyperthermally treating cells

#19

20120093918

2012-04-19

Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof

#20

20120027865

2012-02-02

Water Dispersible Glyceryl Monooleate Magnetic Nanoparticle Formulation

#21

20120004293

2012-01-05

Cancer cell targeting using nanoparticles

#22

20120004177

2012-01-05

Compositions and methods of delivery of pharmacological agents

#23

20110318422

2011-12-29

TARGETED ACTIVE AGENT DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES

#24

20110301248

2011-12-08

Compositions and methods of delivery of pharmacological agents

#25

20110224288

2011-09-15

Cancer cell targeting using nanoparticles

#26

20110200677

2011-08-18

Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer

#27

20100226996

2010-09-09

Compositions and methods of delivery of pharmacological agents

#28

20100209479

2010-08-19

Compositions and methods for treating cancer

#29

20100196490

2010-08-05

Compositions and methods of delivery of pharmacological agents

#30

20090311332

2009-12-17

Method for forming mesoporous silica nanoparticles, mesoporous silica nanoparticles, and applications thereof

#31

20090263331

2009-10-22

Multifunction nanoconjugates for imaging applications and targeted treatment

#32

20090186060

2009-07-23

Methods of enhancing radiation effects with metal nanoparticles

#33

20090061010

2009-03-05

Cancer cell targeting using nanoparticles

#34

20090004228

2009-01-01

Boron compound-layered double hydroxide nanohybrid, method of preparing the boron compound-LDH nanohybrid, and pharmaceutical composition comprising the boron compound-LDH nanohybrid

#35